CN Patent

CN106924237B — 一种含有恩格列净和盐酸二甲双胍的药物组合物

Assigned to HANGZHOU HUADONG MEDICINE GROUP NEW MEDICINE RESEARCH INSTITUTE Co Ltd · Expires 2019-12-03 · 6y expired

What this patent protects

本发明公开了一种含恩格列净和盐酸二甲双胍的药物组合物，含有填充剂、粘合剂、助流剂、润滑剂，其中粘合剂为9‑11％；本发明还公开了一种制备恩格列净和盐酸二甲双胍药物组合物的方法。本发明所公开的恩格列净和盐酸二甲双胍药物组合物硬度大，溶出迅速，片间溶出度RSD小。

USPTO Abstract

本发明公开了一种含恩格列净和盐酸二甲双胍的药物组合物，含有填充剂、粘合剂、助流剂、润滑剂，其中粘合剂为9‑11％；本发明还公开了一种制备恩格列净和盐酸二甲双胍药物组合物的方法。本发明所公开的恩格列净和盐酸二甲双胍药物组合物硬度大，溶出迅速，片间溶出度RSD小。

Drugs covered by this patent

Patent Metadata

Patent number
CN106924237B
Jurisdiction
CN
Classification
—
Expires
2019-12-03
Drug substance claim
No
Drug product claim
No
Assignee
HANGZHOU HUADONG MEDICINE GROUP NEW MEDICINE RESEARCH INSTITUTE Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.